• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014-2018 年辽宁省三个城市代谢相关脂肪性肝病的患病率及相关危险因素:一项流行病学调查。

Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.

机构信息

Gastroenterology Department, The First Hospital of China Medical University, Shenyang, Liaoning, China.

The 3rd Clinical Department, China Medical University, Shenyang, Liaoning, China.

出版信息

BMJ Open. 2022 Feb 17;12(2):e047588. doi: 10.1136/bmjopen-2020-047588.

DOI:10.1136/bmjopen-2020-047588
PMID:35177440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8860048/
Abstract

OBJECTIVE

To investigate the incidence and characteristics of metabolic-associated fatty liver disease (MAFLD) in individuals undergoing physical examination in Liaoning Province (China).

DESIGN

Retrospective study.

SETTING

Single centre.

PARTICIPANTS

Adults who underwent routine health examination at Xikang Medical Center in Liaoning Province (Shenyang, Dandong and Dalian cities) between January 2014 and December 2018.

RESULTS

Among the 204 394 included subjects, 71 756 were diagnosed with MAFLD, accounting for 35.28%. The total prevalence of MAFLD in Shenyang, Dandong and Dalian cities over the past 5 years was 35.8%, 40.41% and 31.7%, respectively. Men had a prevalence of 46.12%, which was higher than in women (21.80%). The percentage of MAFLD in body mass index (BMI) <23 kg/m and ≥23 kg/m was 6.49% and 53.23%, respectively. In all subjects, BMI, systolic blood pressure, diastolic blood pressure (DBP), fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), alanine transaminase, aspartate transaminase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT), blood urea nitrogen, serum creatinine (SCr), serum uric acid (SUA), haematocrit (HCT), mean corpuscular volume (MCV) and urine protein were independently associated with MAFLD (all p<0.001). In lean subjects, DBP, FBG, TG, TC, LDL-C, HDL-C, AST, ALP, GGT, SCr, SUA, HCT and MCV were independently associated with MAFLD (all p<0.001).

CONCLUSION

The prevalence of MAFLD in Liaoning Province was found to be associated with sex, cities with different economic statuses, BMI and multiple metabolic indicators.

摘要

目的

调查中国辽宁省体检人群代谢相关脂肪性肝病(MAFLD)的发病率和特征。

设计

回顾性研究。

地点

单中心。

参与者

2014 年 1 月至 2018 年 12 月期间在辽宁省(沈阳、丹东和大连)禧康医疗中心进行常规健康检查的成年人。

结果

在纳入的 204394 名受试者中,71756 人被诊断为 MAFLD,占 35.28%。过去 5 年,沈阳、丹东和大连的 MAFLD 总患病率分别为 35.8%、40.41%和 31.7%。男性患病率为 46.12%,高于女性(21.80%)。体重指数(BMI)<23kg/m²和≥23kg/m²的 MAFLD 患病率分别为 6.49%和 53.23%。在所有受试者中,BMI、收缩压、舒张压(DBP)、空腹血糖(FBG)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、丙氨酸氨基转移酶、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)、血尿素氮、血清肌酐(SCr)、血清尿酸(SUA)、红细胞压积(HCT)、平均红细胞体积(MCV)和尿蛋白均与 MAFLD 独立相关(均 p<0.001)。在瘦人群体中,DBP、FBG、TG、TC、LDL-C、HDL-C、AST、ALP、GGT、SCr、SUA、HCT 和 MCV 与 MAFLD 独立相关(均 p<0.001)。

结论

辽宁省 MAFLD 的患病率与性别、经济状况不同的城市、BMI 和多种代谢指标有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/9bc833c14239/bmjopen-2020-047588f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/9465c798d214/bmjopen-2020-047588f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/f489b24071c4/bmjopen-2020-047588f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/9bc833c14239/bmjopen-2020-047588f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/9465c798d214/bmjopen-2020-047588f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/f489b24071c4/bmjopen-2020-047588f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe1/8860048/9bc833c14239/bmjopen-2020-047588f03.jpg

相似文献

1
Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.2014-2018 年辽宁省三个城市代谢相关脂肪性肝病的患病率及相关危险因素:一项流行病学调查。
BMJ Open. 2022 Feb 17;12(2):e047588. doi: 10.1136/bmjopen-2020-047588.
2
Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China.中国辽宁胆囊结石与息肉的患病率及危险因素
Front Med (Lausanne). 2022 Apr 25;9:865458. doi: 10.3389/fmed.2022.865458. eCollection 2022.
3
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.甘油三酯-葡萄糖指数与甘油三酯/高密度脂蛋白胆固醇比值在代谢相关脂肪性肝病患者中的诊断价值比较:一项回顾性横断面研究。
Lipids Health Dis. 2022 Jun 25;21(1):55. doi: 10.1186/s12944-022-01661-7.
4
[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].[体检人群中代谢功能障碍相关脂肪性肝病风险预测模型的建立与分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109.
5
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
6
A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.四种特殊中国成年人群腰围、体质指数与收缩压和舒张压的比较和关联,以及临床实验室数据与肥胖高血压的对比研究。
Clin Exp Hypertens. 2018;40(1):16-21. doi: 10.1080/10641963.2017.1281940. Epub 2017 Oct 30.
7
[Application of TG/HDL-C Combined with Liver Function Indexes to Predict Metabolic-Associated Fatty Liver Disease].[甘油三酯/高密度脂蛋白胆固醇联合肝功能指标在预测代谢相关脂肪性肝病中的应用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):764-769. doi: 10.12182/20220960102.
8
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.非肥胖型代谢相关脂肪性肝病的代谢谱和身体组成
Front Endocrinol (Lausanne). 2024 Feb 5;15:1322563. doi: 10.3389/fendo.2024.1322563. eCollection 2024.
9
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
10
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.中国新乡地区代谢相关脂肪性肝病的流行状况及其危险因素分析。
Int J Environ Res Public Health. 2020 Mar 11;17(6):1818. doi: 10.3390/ijerph17061818.

引用本文的文献

1
Comparative effects of different loads of aerobic exercise on lipid metabolism in MASLD rats: a perspective from the gut-liver axis.不同负荷有氧运动对非酒精性脂肪性肝炎大鼠脂质代谢的比较影响:从肠-肝轴角度
Front Med (Lausanne). 2025 Jul 15;12:1609751. doi: 10.3389/fmed.2025.1609751. eCollection 2025.
2
Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort.儿童代谢功能障碍相关脂肪性肝病的潜在替代生物标志物和新型生物标志物:来自中国队列的探索性证据。
BMC Gastroenterol. 2025 Jan 22;25(1):28. doi: 10.1186/s12876-025-03619-2.
3
Protocol for a Longitudinal Cohort Study to Understand Characteristics and Risk Factors Underlying Vibration-Controlled Transient Elastography-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease Children.

本文引用的文献

1
What's in a name? Renaming 'NAFLD' to 'MAFLD'.名字里有什么?将“非酒精性脂肪性肝病”重新命名为“代谢功能障碍相关脂肪性肝病” 。 (备注:MAFLD全称为Metabolic Dysfunction-Associated Fatty Liver Disease ,直译为代谢功能障碍相关脂肪性肝病 ,是对NAFLD(Non-alcoholic Fatty Liver Disease,非酒精性脂肪性肝病)的重新命名 。这里如果仅按字面意思翻译,可能不太能理解其背景含义,补充了备注供你参考。)
Liver Int. 2020 Jun;40(6):1254-1261. doi: 10.1111/liv.14478. Epub 2020 Apr 28.
2
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
3
一项纵向队列研究方案,旨在了解振动控制瞬时弹性成像诊断的代谢功能障碍相关脂肪性肝病儿童的特征和危险因素。
Diabetes Metab Syndr Obes. 2024 Dec 4;17:4627-4639. doi: 10.2147/DMSO.S492809. eCollection 2024.
4
Association Between Serum Uric Acid Levels and Metabolic-Associated Fatty Liver Disease in Southeast China: A Cross-Sectional Study.中国东南部地区血清尿酸水平与代谢相关脂肪性肝病的关联:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Sep 7;17:3343-3354. doi: 10.2147/DMSO.S476045. eCollection 2024.
5
Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征:PolyIran-肝脏研究结果
Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.
6
Metabolic-associated fatty liver disease and sarcopenia: A double whammy.代谢相关脂肪性肝病与肌肉减少症:双重打击。
World J Hepatol. 2024 Feb 27;16(2):152-163. doi: 10.4254/wjh.v16.i2.152.
7
The Global Epidemic of Metabolic Fatty Liver Disease.代谢性脂肪性肝病的全球流行
Curr Cardiol Rep. 2024 Apr;26(4):199-210. doi: 10.1007/s11886-024-02025-6. Epub 2024 Feb 20.
8
[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].[体检人群中代谢功能障碍相关脂肪性肝病风险预测模型的建立与分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109.
9
Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease.代谢相关脂肪性肝病中肝脏线粒体与肠道微生物群的相互作用
Metabolites. 2023 Feb 21;13(3):322. doi: 10.3390/metabo13030322.
Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study.
血清尿酸变化轨迹与非酒精性脂肪性肝病风险:一项前瞻性队列研究
J Transl Med. 2020 Mar 19;18(1):133. doi: 10.1186/s12967-020-02296-x.
4
The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.中国大陆非酒精性脂肪性肝病的流行病学:按调整后人均地区生产总值分析:一项荟萃分析。
Hepatol Int. 2020 Mar;14(2):259-269. doi: 10.1007/s12072-020-10023-3. Epub 2020 Mar 4.
5
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
6
Epidemiological Features of NAFLD From 1999 to 2018 in China.中国 1999 年至 2018 年非酒精性脂肪性肝病的流行病学特征。
Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150.
7
The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.《Lean/非肥胖型非酒精性脂肪性肝病的患病率:系统评价和荟萃分析》。
J Clin Gastroenterol. 2020 Apr;54(4):378-387. doi: 10.1097/MCG.0000000000001270.
8
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.2008 年至 2018 年中国非酒精性脂肪性肝病负担的意外快速增长:系统评价和荟萃分析。
Hepatology. 2019 Oct;70(4):1119-1133. doi: 10.1002/hep.30702.
9
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
10
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).肠道微生物组与非酒精性脂肪性肝病(NAFLD)之间的联系。
Cell Mol Life Sci. 2019 Apr;76(8):1541-1558. doi: 10.1007/s00018-019-03011-w. Epub 2019 Jan 25.